SCHEMBL4308968

SCHEMBL4308968

CCOCC(=O)Nc1cnc2ccccc2c1NCCCCCCl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.45
PKM P14618 1/20 0.45
KMT2A Q03164 1/20 0.45
TOP2A P11388 4/20 0.43
KDM4E B2RXH2 3/20 0.42
POLB P06746 1/20 0.42
ALDH1A1 P00352 3/20 0.41
HTT P42858 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.41
MAPK1 P28482 1/20 0.41
RAB9A P51151 1/20 0.41
HSD17B10 Q99714 1/20 0.41
HRH3 Q9Y5N1 1/20 0.39
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.39
MAPT P10636 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4315442 0.98 MEN1 (0.45) MEN1PKMKMT2ATOP2AKDM4E
SCHEMBL22347101 0.85 BRD4 (0.41) MEN1PKMKMT2ABCHEACHE
Hydrochloric Acid SCHEMBL3864036 0.84 ALDH1A1 (0.41) KMT2AKDM4EPOLBALDH1A1MAPK1
Hydrochloric Acid SCHEMBL4322439 0.84 KDM4E (0.42) MEN1KMT2AKDM4EPOLBALDH1A1
SCHEMBL18179116 0.83 BRD4 (0.41) MEN1PKMKMT2ATOP2ANPC1
SCHEMBL1895375 0.81 KDM4E (0.44) MEN1PKMKMT2AKDM4EPOLB
Hydrochloric Acid SCHEMBL1141137 0.81 MEN1 (0.43) MEN1PKMKMT2ATOP2AKDM4E
SCHEMBL1897264 0.81 MEN1 (0.42) MEN1PKMKMT2ATOP2AKDM4E
SCHEMBL1897056 0.80 KDM4E (0.42) MEN1PKMKMT2AKDM4EPOLB
SCHEMBL2706301 0.79 KDM4E (0.50) MEN1KMT2AKDM4EPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735421-B2 Imidazoquinolinyl sulfonamides 3M INNOVATIVE PROPERTIES COMPANY (US) 2014-05-27 US disclosed
US-20090062272-A1 IMIDAZOQUINOLINYL SULFONAMIDES 3M INNOVATIVE PROPERTIES COMPANY 2009-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062272-A1 IMIDAZOQUINOLINYL SULFONAMIDES IL2, EIF2AK2, IFNG MEN1 4334/4885PKM 3712/4885KMT2A 3200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.